Učitavanje...
Gemcitabine for Advanced Endometrial Cancer: A Review of the MSKCC Experience
BACKGROUND: Gemcitabine has been used in an off-label setting for treatment of advanced endometrial cancer (EMC), but there is a lack of published data showing its efficacy in treating this disease. We performed a retrospective review to determine the progression-free survival (PFS) and response rat...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3904291/ https://ncbi.nlm.nih.gov/pubmed/22635030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0b013e31824a33a2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|